Diffuse alveolar hemorrhage with nivolumab monotherapy

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

We describe a 60 year old man who developed respiratory insufficiency after treatment with 2 rounds of nivolumab monotherapy. Imaging revealed subtle ground glass infiltrates which progressed to diffuse opacities and consolidation. The patient was treated with high dose corticosteroids, empiric antimicrobial therapy and infliximab. Bronchoscopy with lavage revealed negative cultures and progressive bloody aliquots of fluid consistent with diffuse alveolar hemorrhage. The patient succumbed to respiratory failure. An autopsy study confirmed extensive alveolar hemorrhage. Our reports highlights clinical and diagnostic findings with immunotherapy-induced pneumonitis.

Original languageEnglish (US)
Article number101131
JournalRespiratory Medicine Case Reports
Volume30
DOIs
StatePublished - 2020

Keywords

  • Cancer
  • Diffuse alveolar hemorrhage
  • Drug-induced pneumonitis
  • Immune checkpoint inhibitor
  • Immunotherapy

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Diffuse alveolar hemorrhage with nivolumab monotherapy'. Together they form a unique fingerprint.

Cite this